Biogen Acquires Apellis Pharmaceuticals
Biogen acquired Apellis Pharmaceuticals for $5.6B. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Biogen
- Acquired Company
- Apellis Pharmaceuticals
- Price
- $5.6B
- Acquisition Type
- Acquisition
- Announced
- March 31, 2026
Canonical: https://fsome.com/acquisitions/biogen-acquires-apellis-pharmaceuticals-17228172 · For the full deal terms, timeline, and press references, please enable JavaScript.